United States Coverage, Breaking News & Insight

Official Audi media image accompanying the Georgia manufacturing announcement

Audi Plans $4 Billion Georgia SUV Plant, With Production Years Away

Audi plans a $4 billion Georgia factory with capacity for 200,000 vehicles annually and approximately 4,500 jobs. Company and state timelines place production in the early 2030s, making the announcement a long-term

October 25, 2026

Auto & Transport·Business·News

Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)

Longer-term data reflecting nearly 4 years of follow-up show a further reduction in the risk of death from 14% to 37% for those initially treated with Libtayo, despite an 88% crossover from

October 25, 2026

Business·Press Release

Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026

Low dose (200 mg) budoprutug demonstrated B-cell depletion, PLA2R Ab reduction, and immunologic remission at 12 weeks, consistent with Phase 1b data; additional data from the PrisMN Phase 2 study anticipated in

October 24, 2026

Business·Press Release

US and Chinese national flags in Tiananmen Square, Beijing, in a file photograph

China Challenges US Plan to Widen Tech-Investment Curbs

China has urged the US to halt proposed wider curbs on investment in sensitive technologies, including biotechnology. Treasury's draft distinguishes prohibited and notifiable transactions, with comments due December 7 and an effective

October 24, 2026

Business·Economy·News

Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors

Objective response rate of 72.2% among response-evaluable patients receiving a starting dose of ≥450 mg at 32-week landmark Disease control rate of 100% across all response-evaluable patients receiving a starting dose of

October 24, 2026

Business·Press Release

Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

As published in the Journal of Clinical Oncology (JCO) and presented at ESMO, COMPANION-002 met its primary endpoint of ORR and key secondary endpoint of PFS, with a 56% reduction in the

October 24, 2026

Business·Press Release

Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026

Median PFS was 21.5 months with the gedatolisib triplet and 11.5 months with the gedatolisib doublet versus 9.1 months with alpelisib + fulvestrant in patients who had no liver metastases ORR and

October 24, 2026

Business·Press Release

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

PRINCETON, N.J., Oct. 23, 2026 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its third quarter 2026 financial results on Thursday,

October 24, 2026

Business·Press Release

Atari Begins Trading on OTCQX Best Market

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Atari (Euronext Paris: ALATA; OTCQX:

October 24, 2026

Business·Press Release

ACT Energy Technologies Ltd. Begins Trading on OTCQX Best Market

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ACT Energy Technologies Ltd. (TSX:

October 24, 2026

Business·Press Release

United States

Audi Plans $4 Billion Georgia SUV Plant, With Production Years Away

Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)

Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026

China Challenges US Plan to Widen Tech-Investment Curbs

Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors

Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

Atari Begins Trading on OTCQX Best Market

ACT Energy Technologies Ltd. Begins Trading on OTCQX Best Market

Radical Islam is being appreciated by Indian authorities too

Bangladesh; India’s Biggest Ally or China’s Dragon Nest?

Ahmadis in Bangladesh face fresh threat of persecution

Latest Posts

Audi Plans $4 Billion Georgia SUV Plant, With Production Years Away

Putin Calls Attempts to Accuse Russia of Inciting Unrest in Europe Clear Exaggeration

Russia Offers Farm Tech to Africa Ahead of Moscow Summit

Euro Zone Growth Slows to Four-Month Low as France Slides Back Into Contraction

United States

Follow

Latest Posts